In this Phase I study, three different doses (low, medium and high dose, on the basis of
surface area applied) of GN-037 cream (12 volunteers in total) and placebo (6 volunteers in
total) will be administered to healthy volunteers. In the active dose arm, 4 healthy
volunteers will receive GN-037 cream and 2 healthy volunteers will receive placebo.
Randomization in each dose arm will be 2:1.